Pointing in a similar direction, treatment of STING-defective human melanoma cell lines with the DNA methyltransferase inhibitor 5-aza-2’-deoxycytidine (5AZADC) reinstated functional STING signaling and IFN-β secretion after 2,3-cGAMP treatment (44). Here, STING1 is linked to melanoma.